Sugi Predict

Sugi Predict / Compounds / SCHEMBL648889

SCHEMBL648889

SCHEMBL648889

CCOC(=O)C(=Cc1ccccc1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.70
▸ KMT2A Q03164 7/20 0.70
▸ AKR1C1 Q04828 1/20 0.58
▸ MAPT P10636 10/20 0.55
▸ LMNA P02545 6/20 0.55
▸ NPSR1 Q6W5P4 5/20 0.55
▸ HTT P42858 3/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ ALDH1A1 P00352 5/20 0.53
▸ NR1H4 Q96RI1 1/20 0.52
▸ HPGD P15428 5/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ HSP90AA1 P07900 1/20 0.52
▸ CYP2C9 P11712 3/20 0.51
▸ CYP2C19 P33261 3/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ S1PR4 O95977 1/20 0.51
▸ S1PR1 P21453 1/20 0.51
▸ CYP2D6 P10635 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7527305 1.00 MEN1 (0.70) MEN1KMT2AAKR1C1MAPTLMNA
SCHEMBL24704034 1.00 MEN1 (0.70) MEN1KMT2AAKR1C1MAPTLMNA
SCHEMBL7248148 0.90 MEN1 (0.64) MEN1KMT2AAKR1C1MAPTLMNA
SCHEMBL7248152 0.90 MAPT (0.64) MEN1KMT2AAKR1C1MAPTLMNA
SCHEMBL14970302 0.88 KMT2A (0.55) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL4194919 0.87 LMNA (0.56) MEN1KMT2AAKR1C1MAPTLMNA
SCHEMBL27973355 0.86 KMT2A (0.53) MEN1KMT2AAKR1C1MAPTLMNA
SCHEMBL8164258 0.85 MAPT (0.76) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL9744529 0.85 KMT2A (0.55) MEN1KMT2AMAPTLMNANPSR1
SCHEMBL7931342 0.84 KDM4E (0.54) MEN1KMT2AAKR1C1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 493 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12239209-B2 System for dispensing a cosmetic product L'OREAL (FR) 2025-03-04 — — US claimed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 — — US claimed
EP-4391827-A1 METHOD OF MITIGATING OFF-ODORS Givaudan SA (CH) 2024-07-03 — — EP claimed
CN-116693393-A Method for purifying phenethyl cinnamate and preparation process thereof 安徽锦戎香料有限公司 2023-09-05 — — CN claimed
WO-2023025549-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2023-03-02 — — WO claimed
US-20220160108-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2022-05-26 — — US claimed
US-10953256-B2 Composition comprising fluorine-containing ketone SINOCHEM LANTIAN CO., LTD (CN) 2021-03-23 — — US claimed
CN-109674667-A A kind of hair washing essence that fragrance retention is lasting 广州积美国际贸易有限公司 2019-04-26 — — CN claimed
CN-105199851-B A kind of cream odor type flavouring essence for tobacco 河南中烟工业有限责任公司 2019-03-08 — — CN claimed
CN-109188573-A A kind of dipping process of anti-blue light resin lens surface stiffened film 江苏硕延光学眼镜有限公司 2019-01-11 — — CN claimed
WO-2008141333-A1 TASTE POTENTIATOR COMPOSITIONS IN ORAL DELIVERY SYSTEMS CADBURY ADAMS USA LLC (US) 2008-11-20 — — WO claimed
US-20070166341-A1 Solid volatile composition and method and system for making the same INTERNATIONAL ARTS & SCIENCE GROUP, INC. 2007-07-19 — — US claimed
CN-1572335-A Self-Service respiratory vaccination instrument for SARS infectious disease CONG FANZI (CN) 2005-02-02 — — CN claimed
CN-1520846-A Quick-effective aerosol with plant aroma and its preparation 丛繁滋 2004-08-18 — — CN claimed
CN-1500477-A Quick result aerosol with plant aroma and its preparation 丛繁滋 2004-06-02 — — CN claimed
CN-1475204-A Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method 丛繁滋 2004-02-18 — — CN claimed
CN-1137676-C Cosmetic filter compositions containing dibenzoylmethane, beta, beta'-diphenylacrylate and benzotriazole silicone and its use �ź㴫 2004-02-11 — — CN claimed
CN-1081456-C Compositions contg. 4-t-butyl-4'-methoxy-dibenzoylmethane, 1,3,5-triazine deriv. and alkyl(alpha-cyano)-beta, beta'-diphenylacrylate and uses OREAL (FR) 2002-03-27 — — CN claimed
CN-1224344-A Compositions contg. 4-t-butyl-4'-methoxy-dibenzoylmethane, 1,3,5-triazine deriv. and alkyl(alpha-cyano)-beta, beta'-diphenylacrylate and uses OREAL (FR) 1999-07-28 — — CN claimed
CN-1188406-A Cosmetic filter compositions containing dibenzoylmethane, beta, beta'-diphenylacrylate and benzotriazole silicone and its use OREAL (FR) 1998-07-22 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220160108-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT PDE12, SAMM50, POLR1C MEN1 766/4885KMT2A 1441/4885AKR1C1 1090/4885
US-12239209-B2 System for dispensing a cosmetic product PDE12, SAMM50, POLR1C MEN1 766/4885KMT2A 1441/4885AKR1C1 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.